This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Experimental strategies to achieve efficient targeted knock-in via tandem paired nicking
Scientific Reports Open Access 19 November 2021
-
Accelerated apoptotic death and in vivo turnover of erythrocytes in mice lacking functional mitogen- and stress-activated kinase MSK1/2
Scientific Reports Open Access 27 November 2015
-
Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
Oncogene Open Access 11 March 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Wadleigh M, DeAngelo DJ, Griffin JD, Stone RM . After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies. Blood 2005; 105: 22–30.
Stone RM, DeAngelo DJ, Klimek V, Galinsky I, Estey E, Nimer SD et al. Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412. Blood 2005; 105: 54–60.
Thomson S, Clayton AL, Hazzalin CA, Rose S, Barratt MJ, Mahadevan LC . The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J 1999; 18: 4779–4793.
Furukawa Y, Vu HA, Akutsu M, Odgerel T, Izumi T, Tsunoda S et al. Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus negative leukemia cell lines. Leukemia 2007; 21: 1005–1014.
Kim H-G, Lee KW, Cho Y-Y, Kang NJ, Oh S-M, Bode AM et al. Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation. Cancer Res 2008; 68: 2538–2547.
Srinivasa SP, Doshi PD . Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways cooperate in mediating cytokine-induced proliferation of a leukemic cell line. Leukemia 2002; 16: 244–253.
Parmar S, Katsoulidis E, Verma A, Li Y, Sassano A, Lal L et al. Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells. J Biol Chem 2004; 279: 25345–25352.
Dumka D, Puri P, Carayoi N, Balachandran H, Schuster K, Verma AK et al. Activation of the p38 MAP kinase pathway is essential for the antileukemic effects of dasatinib. Leuk Lymphoma 2009; 50: 2017–2029.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website (
Rights and permissions
About this article
Cite this article
Odgerel, T., Kikuchi, J., Wada, T. et al. MSK1 activation in acute myeloid leukemia cells with FLT3 mutations. Leukemia 24, 1087–1090 (2010). https://doi.org/10.1038/leu.2010.48
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.48
This article is cited by
-
Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling
Leukemia (2023)
-
Experimental strategies to achieve efficient targeted knock-in via tandem paired nicking
Scientific Reports (2021)
-
Accelerated apoptotic death and in vivo turnover of erythrocytes in mice lacking functional mitogen- and stress-activated kinase MSK1/2
Scientific Reports (2015)
-
Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
Oncogene (2013)